Fundraising Fox

Medical Devices Startups

6,529 companies tagged Medical Devices, with their investors and founders.

GID BIO

GID BIO develops investigational adipose-derived cell therapies and device platforms aimed at offering physicians and patients alternatives between short-term relief and major surgery. The company operates in the regenerative medicine and medical device space.

0 investors

Global Continence

Global Continence develops medical devices and treatments for pediatric urological conditions, including incontinence and voiding dysfunction. The company is led by pediatric urologists and serves patients globally through innovative surgical techniques and products.

0 investors

Goldenrod Therapeutics, Inc.

Goldenrod Therapeutics develops brain-penetrant phosphodiesterase 4 inhibitors for neurological and neuropsychiatric disorders, focusing on overcoming tolerability limitations of earlier PDE4 inhibitors to address neuroinflammation.

0 investors

Grace Therapeutics

Grace Therapeutics is a biopharmaceutical company developing therapies for aneurysmal subarachnoid hemorrhage (aSAH), a condition with high mortality and morbidity that affects a relatively young patient population. The company is publicly traded and provides investor updates on its drug development pipeline.

0 investors

Gravitas Medical

Gravitas Medical develops the Entarik Feeding Tube System, a medical device that assists in feeding tube placement and continuously monitors tube position using bio-impedance sensors and safety alerts. The system is designed for healthcare facilities and ICU nurses managing enteral nutrition for patients unable to feed orally.

0 investors

Greyledge Technologies

Greyledge Technologies develops diagnostic and cell-analysis equipment and services for regenerative medicine practitioners to characterize biologic treatments like PRP and stem cell therapies. The company works with physicians and biotech providers to enable precise cell quantification and FDA-compliant cellular therapy delivery.

0 investors

GRIP Molecular Technologies

GRIP Molecular Technologies develops a diagnostic platform built on a CRISPR protease engine that detects pathogen RNA (bacteria, viruses, fungi) from saliva, swab, and urine samples with molecular-grade accuracy in minutes at ambient temperature. It targets point-of-care and point-of-need testing for sexually transmitted, urinary tract, and upper respiratory infections, adaptable to lateral flow, electrochemical, and colorimetric readouts.

0 investors

GT Biopharma

GT Biopharma is a clinical-stage immuno-oncology company developing targeted cancer immunotherapies using proprietary NK cell engager technology. The company focuses on creating therapeutic agents that simultaneously engage natural killer cells and cancer cells to facilitate selective cancer cell elimination.

0 investors

GuideAI Health

GuideAI Health builds AI software for detecting peripheral artery disease (PAD) in routine CT scans, automatically flagging signs of blocked or narrowed arteries in the lower legs to prioritize urgent cases for radiologist review. The platform serves hospitals and radiology practices operating in a $200B+ market, with FDA clearance obtained in June 2026 for its VascularAssist Occlusion Triage product.

0 investors

Guided Clinical Solutions

Guided Clinical Solutions makes GuidedOR, a medication safety software platform that integrates with electronic health records and vital sign monitors to provide real-time safety checks, dosing recommendations, and alerts as clinicians administer medications during surgery. The product, originally developed at Massachusetts General Hospital and Harvard Medical School, is sold to hospitals and surgical centers to reduce operating room medication errors and improve documentation efficiency.

0 investors

Guided Therapeutics

Guided Therapeutics develops medical devices based on patented biophotonic technology to detect diseases earlier, with its flagship LuViva Advanced Cervical Scan identifying tissue changes that are early signs of cervical cancer. The company sells to physicians and healthcare systems, with an international distribution presence including China.

0 investors

Gulf Sterilization

Gulf Sterilization is a contract sterilization facility that uses chlorine dioxide gas to sterilize medical devices, including heat-sensitive materials, electronics, and combination drug delivery products, for medical device manufacturers. The ISO 13485:2016-certified, woman-owned facility is located near a deep water port and major interstates for logistics access.

0 investors

Hallux

Hallux Inc. develops Hallux Subungual Gel (HSG), a physician-administered terbinafine treatment applied directly to the nail bed to treat onychomycosis (fungal nail infection). The pharmaceutical product is being evaluated in clinical trials for use by podiatrists and dermatologists at the point-of-care.

0 investors

Hapten Sciences

Hapten Sciences develops early-stage pharmaceutical products focused on dermatological health, with its lead candidate PDC-APB in clinical development as a preventive immunotherapy for contact dermatitis caused by exposure to poisonous plants. The company targets healthcare providers and individuals affected by urushiol-related skin conditions.

0 investors

Hastings Medical Imaging

Hastings Radiology Associates provides diagnostic imaging services including CT, MRI, ultrasound, mammography, and interventional procedures to patients in central Nebraska and north central Kansas.

0 investors

Hawkeye Surgical Lighting

Hawkeye Surgical Lighting is associated with surgical lighting products, but the page contains only a copyright notice with no substantive description of its offerings.

0 investors

HDL Therapeutics

HDL Therapeutics is a commercial-stage biotechnology company with an FDA-approved therapy that reduces coronary atheroma in a rare cardiovascular disease. The company develops therapies targeting cardiovascular, neurodegenerative, autoimmune, viral, and peripheral vascular diseases.

0 investors

Headlands Research

Headlands Research operates a multinational clinical trial site network that recruits and retains diverse participant populations for medical research studies. The organization supports pharmaceutical sponsors and research sites in advancing innovative therapies through operational excellence and high-quality data collection across multiple therapeutic areas.

0 investors

HealthPartners

HealthPartners is a health system and health insurance organization that provides medical care and coverage while working to reduce health disparities in the communities it serves. It focuses on advancing health equity in chronic disease care, preventive screenings, and maternal and child health.

0 investors

HeartHero

HearHero works to raise awareness of Sudden Cardiac Arrest and expand access to defibrillation, in partnership with cardiovascular care organizations. It operates in the cardiac health and emergency medical device space.

0 investors

Heligenics

Heligenics is a genomics and cell biology company that develops assays and platforms for drug screening and genetic analysis. The company serves pharmaceutical and biotech organizations conducting research in functional genomics and cellular engineering.

0 investors

Helocyte

Helocyte is a biotechnology company developing cell-based therapies and life sciences programs. The company focuses on advancing breakthrough treatments within the biotech and life sciences sector.

0 investors

Hemanext

Hemanext develops oxygen-controlled storage technology to preserve red blood cell quality and function during transfusion storage. The company serves hospitals and blood establishments seeking to improve patient outcomes in transfusion medicine.

0 investors

Hepion Pharmaceuticals

Hepion Pharma is a pharmaceutical company with a therapeutic focus on hepatocellular carcinoma (liver cancer). This page is an investor presentations section with no substantive content available.

0 investors

Other sectors & tags